Results 81 to 90 of about 55,376 (183)

Breast cancer and ATM mutations: treatment implications. [PDF]

Hered Cancer Clin Pract
Seca M, Narod SA.
europepmc   +1 more source

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

New England Journal of Medicine, 2002
T. Rebbeck, H. Lynch, S. Neuhausen, S. Narod, L. V. van’t Veer, J. Garber, G. Evans, C. Isaacs, M. Daly, E. Matloff, O. Olopade, B. Weber   +11 more
semanticscholar   +1 more source

The Effect of Blood Selenium Level on the pCR Rate in Breast Cancer Patient Receiving Neoadjuvant Chemotherapy. [PDF]

Cancers (Basel)
Szwiec M, Tomiczek-Szwiec J, Marciniak W, Derkacz R, Huzarski T, Cybulski C, Gronwald J, Osowiecka K, Sibilski R, Narod SA, Lubiński J.   +10 more
europepmc   +1 more source

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment. [PDF]

Br J Cancer, 2023
Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, Lubinski J, Huzarski T, Hyder Z, Forde C, Metcalfe K, Senter L, Weitzel J, Tung N, Zakalik D, Ekholm M, Sun P, Narod SA, kConFab Investigators, Polish Hereditary Breast Cancer Consortium, Hereditary Breast Cancer Clinical Study Group.   +20 more
europepmc   +1 more source

Narod, država in identitete v obmejnih prostorih

, 2010
Borders have been subject to various types of inquiry in the social sciences and humanities, spanning the fields of the political geographical, social anthropological, sociological, as well as political and cultural history. This paper focuses on the theoretical aspects of investigating borderness and outlines the development of the area which has ...
openaire   +2 more sources

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Journal of Clinical Oncology, 2004
T. Rebbeck, T. Friebel, H. Lynch, S. Neuhausen, Laura van ‘t Veer, J. Garber, G. Evans, S. Narod, C. Isaacs, E. Matloff, M. Daly, O. Olopade, B. Weber   +12 more
semanticscholar   +1 more source

The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation. [PDF]

Cancer
Katona BW, Lubinski J, Pal T, Huzarski T, Foulkes WD, Moller P, Eisen A, Randall Armel S, Neuhausen SL, Raj R, Aeilts A, Singer CF, Bordeleau L, Karlan B, Olopade O, Tung N, Zakalik D, Kotsopoulos J, Fruscio R, Eng C, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group.   +22 more
europepmc   +1 more source

BRCA1 and BRCA2 Mutations in Polish Women with Ductal Carcinoma In Situ. [PDF]

Cancers (Basel)
Feszak S, Feszak IJ, Kluźniak W, Wokołorczyk D, Stempa K, Gliniewicz K, Uciński J, Huzarski T, Dębniak T, Gronwald J, Lubiński J, Narod SA, Cybulski C.   +12 more
europepmc   +1 more source

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

Journal of the National Cancer Institute, 2006
H. Risch, J. McLaughlin, D. Cole, B. Rosen, L. Bradley, I. Fan, James Tang, Song Li, Shiyu Zhang, P. Shaw, S. Narod   +10 more
semanticscholar   +1 more source

A Zebra in Horse's Clothing: Rethinking the Diagnosis of Rare Diseases. [PDF]

Mol Genet Genomic Med
Dutta R, Duong C, Kimonis V, Xiao C.
europepmc   +1 more source